搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 天
FDA授予Elraglusib治疗软组织肉瘤孤儿药资格
FDA 已授予 elraglusib 孤儿药资格(ODD),用于治疗软组织肉瘤(STS)患者。 目前,一项 2 期开放标签 2 层试验正在评估 elraglusib 与吉西他滨和多西他赛联合治疗 10 ...
13 天
Actuate获得FDA孤儿药资格认定用于癌症治疗
芝加哥和德克萨斯州沃思堡 - 临床阶段生物制药公司Actuate Therapeutics, Inc. (NASDAQ: ACTU)宣布,美国食品和药物管理局(FDA)已授予其研究性药物elraglusib用于软组织肉瘤(STS)治疗的孤儿药资格认定(ODD)。这一认定是elraglusib的重要里程碑,该药物是一种新型的糖原合成酶激酶-3β(GSK-3β)抑制剂,GSK-3β是一种参与肿瘤生长和 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Would-be assassin charged
Gets 2-yrs for role in fraud
Woman dies in 'suicide pod’
Diagnosed with Parkinson's
Phoenix breaks heat record
‘Trump Train’ jury verdict
Contempt charge coming?
Haitian group files complaint
Food packaging cancer risk
Foreign incentives offer?
OR removes 1,200+ voters
Devils Tower climber dies
To shut down TikTok Music
Gold prices hit all-time high
Calls for US to lift sanctions
Russian aircraft detected
1st NL East title since 2011
Won't call special session
Partners with Google
Dali owner, operator sued
Helene forms in Caribbean
NC sending absentee ballots
EEOC blocked on rules
PA county ballot ruling
Recalls 41K+ motorcycles
Calif. school phone ban law
Outlaws guitarist dies
Study about oceans' acidity
DOJ sues Visa
Severe obesity on the rise
Conn. counterfeit drug bust
反馈